TrialWorld journal of gastroenterology2007

Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.

Laurent Peyrin-Biroulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.